ATH 0.00% 0.3¢ alterity therapeutics limited

Another abstract in AAN virtual meeting, page-13

  1. 142 Posts.
    lightbulb Created with Sketch. 60
    More than interesting. "Concentrations of NfL in CSF and plasma changed in parallel with disease progression in the MSA mouse model..." and they specifically noted "marked increases between 6 and 12 months" answering my concern of time frame.

    Your suggestion of using NFL screening at ...say the age of fifty or even forty, since there is suspicion of neuro-degenerative processes beginning (very early stages) in the forties. They didn't differentiate between using plasma or CSF, so creating baseline measures earlier on wouldn't be that onerous. Automatic updates every five years would be a diagnostic tool and give a "heads up" if things were going off the tracks.

    While interesting - it's PBT434 (and PBT2) that I'm interested in. At their current rate of progress, I'll be reviewing the deed on a cloud palace (I wonder if it comes with a harp or do you have to byoh?) before they become available.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $1.633K 487.8K

Buyers (Bids)

No. Vol. Price($)
20 32189472 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126368541 15
View Market Depth
Last trade - 16.10pm 08/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.